If you happen to have PAD or CAD especially an advanced stage (e.g., angina in CAD, severely restricted circulation in PAD), NCIM wants to make you aware of its own advances in this area:
(1) NCIM’s Beacon Factor given by intravenous means substantially increased the blood flow in both children and adults with impeded circulation including (in adults) blocked blood vessels. It not only did this during the time it was being administered but kept up the better blood flow for weeks and even months afterwards. This, of course, is not a “permanent solution” to PAD or CAD and is not advocated as such. It is, in fact, only used to “get things going”; that is, to improve blood flow short term in order to set the stage for #2 below.
(2) Following a few days of Beacon Factor infusions, patients are given a regimen for reversing arterial blockage; one worked out over many years by one of NCIM’s consulting researchers who first established its ability to reverse arterial plaque in animal models of CAD, and then entrusted it to physicians who utilized it on patients with PAD and CAD, kept track of responses and documented CAD reversal. This regimen has dietary, pharmaceutical and supplement components to it.
For instance, during 2012 the regimen was used by a gentleman with advanced PAD who was wheelchair bound and facing amputation of his lower legs. After 8 months on it this fellow’s MD surgeon declared that his blood flow was such that amputation was “no longer a consideration”.
The NCIM Beacon Factor and special regimen to reverse PAD and CAD is, of course, experimental and as such carries a certain element of risk and is not guaranteed as to outcome. This will be spelled out during the informed consent process.
Each case, of course, requires careful evaluation including a comprehensive records review to determine whether the patient is a suitable candidate for NCIM’s PAD/CAD reversing treatment approach. Those interested in learning more or being evaluated (there is no charge or obligation) should contact NCIM by phone at 1-562-916-3410 from 10 am to 7 pm Pacific Time, Monday through Friday or by email at NCInfodesk@gmail.com